Novavax Inc. Stock Sheds 6.3%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Novavax Inc. slid 6.3% to $10.20 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.7% to 25,065.87 and Dow Jones Industrial Average falling 0.3% to 52,231.89.

The stock's fall snapped a two-day winning streak.

Novavax Inc. closed 23.8% short of its 52-week high of $13.39, which the company achieved on October 5th.

The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 0.5% to $280.78, Pfizer Inc. rose 0.4% to $29.36, and Merck & Co. Inc. fell 0.48% to $148.05.

Trading volume totaled 8.5 million, compared to the 50-day average of 7.0 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

November 10, 2026 16:32 ET (21:32 GMT)